Skip to main content
    Straight from the Cutter’s Mouth

    Drs. Avni Finn and Shriji Patel join to discuss big takeaways from the 2022 AAO Annual Meeting, including discussion of biosimilars, dry AMD treatments, high-dose aflibercept, and private equity influence in the retina community.

    Relevant Financial Disclosures:
    Dr. Sridhar is a consultant for Alcon, Allergan, Apellis, DORC, Genentech, Ocuterra, and Regeneron. Dr. Finn is a consultant for Allergan and Genentech. Dr. Patel has no relevant disclosures.